It is the broad, long-term goal of the Hematologic Malignancies Research Program to build on and extend the current knowledge in the field of bone marrow transplantation and hematological malignancies.
This program is a multidisciplinary clinical, basic and translational research effort whose overall goal is to improve outcomes for patients with solid and liquid malignancies.
To this end, the investigators of this application will utilize the approach of translational research, bridging the novel experimental concepts and observations made at the laboratory bench to clinical application at the patients’ bedsides. In both basic and clinical areas, the program fosters interactions between many programs and members of the Duke Cancer Institute.
The aims of the program are to: